Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763153
2.
Bench to Bedside Development of [18F]Fluoromethyl-(1,2-2H4)choline ([18F]D4-FCH).
Molecules
; 28(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38138508
3.
Prostate cancer in transgender women: what does a urologist need to know?
BJU Int
; 129(1): 113-122, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157213
4.
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
J Med Econ
; 26(1): 1099-1107, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656223
5.
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer.
Eur Urol Open Sci
; 36: 9-18, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34977691
6.
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study.
BMJ Open
; 11(11): e048996, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794989
7.
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
Prostate Cancer Prostatic Dis
; 24(4): 1120-1128, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934114
8.
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.
BMJ Open
; 11(2): e042953, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632752
9.
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer.
JAMA Oncol
; 5(12): 1774-1778, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31513236
10.
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
Cancer Res
; 64(20): 7201-4, 2004 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15492233
11.
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome.
Oncogene
; 23(35): 5871-9, 2004 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15184867
12.
Amplification and overexpression of E2F3 in human bladder cancer.
Oncogene
; 23(8): 1627-30, 2004 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-14716298
13.
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.
Cancer Epidemiol Biomarkers Prev
; 14(2): 397-402, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15734964
14.
ATM protein overexpression in prostate tumors: possible role in telomere maintenance.
Am J Clin Pathol
; 121(2): 231-6, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14983937
15.
Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options.
Urol Ann
; 4(1): 45-7, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22346102
16.
Does low to moderate alcohol intake protect against cognitive decline in older people?
J Am Geriatr Soc
; 56(12): 2217-24, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19093921
17.
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Am J Hum Genet
; 72(1): 1-12, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12474142